封面
市场调查报告书
商品编码
1391913

深奥的测试市场:按类型、按技术、按服务供应商、按地区

Esoteric Testing Market, By Type, By Technology, By Service Provider, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 150 Pages | 商品交期: 2-3个工作天内

价格
简介目录

Esoteric 测试市场规模预计将从 2023 年的 259 亿美元增至 2030 年的 549 亿美元,预测期内复合年增长率为 11.3%。

报告范围 报告详情
基准年 2022年 2023年市场规模 259亿美元
实绩资料 2018-2021 预测期 2023-2030
预测期复合年增长率 11.30% 2030年市场规模预测 549亿美元
图 1. 2023 年全球市场占有率(%)(按地区)
深奥的测试市场-IMG1

近年来,随着技术和医学研究的进步导致高度专业化的诊断测试的发展,深奥的测试领域受到了极大的关注。深奥测试是不常见的实验室测试,需要专门的设备、专业知识和解释。这些检查通常用于诊断罕见疾病、监测治疗效果并提供个人化医疗解决方案。

由于慢性病盛行率的增加、基因检测的进步以及个人化医疗需求的不断增长等因素,全球深奥检测市场正在显着成长。深奥的检测在识别基因突变、生物标记和其他分子异常方面发挥重要作用,有助于早期疾病检测和治疗。

市场动态:

全球深奥检测市场主要是由癌症、心血管疾病和自体免疫疾病等慢性疾病盛行率上升所推动的。深奥的测试使医疗专业人员能够识别与这些疾病相关的特定基因突变和生物标记物,从而促进早期诊断和个体化治疗计划。此外,精准医学和标靶治疗的日益普及也进一步推动了对深奥测试的需求。

然而,深奥的测试面临成本高、报销政策不充分等挑战。由于执行这些测试需要专门的设备和专业知识,困难的测试通常价格昂贵。此外,保险公司承保范围有限也阻碍了这些测试的广泛普及,特别是在发展中地区。

儘管存在这些挑战,市场仍存在一些成长机会。对预防性医疗保健的日益关注以及对早期疾病检测益处的日益认识预计将推动对深奥检测的需求。此外,次世代定序和分子诊断等技术进步可能会提高深奥测试的准确性和效率,为市场扩张开闢新途径。

本研究的主要特点

  • 本报告对全球 Esoteric 测试市场进行了详细分析,包括以 2022 年为基准年的预测期(2023-2030)的市场规模和年复合成长率(CAGR%)。
  • 它还揭示了各个细分市场的潜在商机,并为该市场说明了一系列有吸引力的投资提案。
  • 它还提供了有关市场驱动因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要考察。
  • 该报告的见解将使公司行销人员和负责人能够就未来的产品发布、升级、市场扩张和行销策略做出资讯的决策。
  • 本研究报告针对该产业的各个相关人员,如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
  • 透过用于分析全球持续测试市场的各种策略矩阵,将有助于相关人员做出决策。

目录

第一章 研究目的与假设

  • 研究目标
  • 假设
  • 简称

第二章 市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map(COM)

第三章市场动态、法规及趋势分析

  • 市场动态
    • 促进因素
  • 慢性病及感染疾病率增加
    • 抑制因素
  • 费用高且报销不足
    • 机会
  • 护理点深奥测试
  • 影响分析
  • 主要亮点
  • 监管场景
  • 产品发布/核准
  • PEST分析
  • 波特的分析
  • 併购场景

第 4 章 深奥的测试市场 –冠状病毒(COVID-19) 大流行的影响

  • 新型冠状病毒感染疾病(COVID-19)的流行病学
  • 供需面分析
  • 经济影响

第 5 章 深奥测试市场,按类型,2018-2030

  • 介绍
  • 内分泌学
  • 肿瘤学
  • 分子诊断
  • 神经病学
  • 免疫学
  • 基因检测
  • 其他的

第 6 章 深奥测试市场(按技术),2018-2030

  • 介绍
  • 质谱
  • 实时萤光定量PCR
  • 流式细胞仪
  • 化学冷光
  • 酵素连结免疫吸附试验
  • 免疫测量
  • 其他的

第 7 章 深奥测试市场,按服务供应商划分,2018-2030

  • 介绍
  • 独立实验室和参考实验室
  • 医院实验室
  • 专科诊所
  • 其他的

第 8 章 2018-2030 年深奥测验市场(按地区)

  • 介绍
  • 北美洲
  • 美国
  • 加拿大
  • 欧洲
  • 英国
  • 德国
  • 义大利
  • 法国
  • 西班牙
  • 俄罗斯
  • 欧洲其他地区
  • 亚太地区
  • 中国
  • 印度
  • 日本
  • 东南亚国协
  • 澳洲
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
  • 中东
  • 海湾合作委员会国家
  • 以色列
  • 其他中东地区
  • 非洲
  • 北非
  • 中部非洲
  • 南非

第9章竞争形势

  • LabCorp
  • Quest Diagnostics
  • OPKO Health
  • Miraca Holdings
  • Myriad Genetics
  • Sonic Healthcare
  • Cardio Diagnostics Holdings, Inc
  • Veravas
  • BPGbio, Inc.
  • Fulgent Genetics
  • Alveo Technologies, Inc.
  • RL Diagnostics

第10章

  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI6261

The esoteric testing market size is expected to reach US$ 54.9 billion by 2030, from US$ 25.9 million in 2023, at a CAGR of 11.3% during the forecast period.

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 25.9 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 11.30% 2030 Value Projection: US$ 54.9 Bn
Figure 1. Global Esoteric Testing Market Share (%), by Region, 2023
Esoteric Testing Market - IMG1

The field of esoteric testing has gained significant attention in recent years, as advancements in technology and medical research have allowed for the development of highly specialized diagnostic tests. Esoteric testing refers to laboratory tests that are not commonly performed and require specialized equipment, expertise, and interpretation. These tests are often used to diagnose rare diseases, monitor treatment effectiveness, and provide personalized healthcare solutions.

The global esoteric testing market is witnessing substantial growth, driven by factors such as the increasing prevalence of chronic diseases, advancements in genetic testing, and the growing demand for personalized medicine. Esoteric testing plays a crucial role in identifying genetic mutations, biomarkers, and other molecular abnormalities that can help in the early detection and treatment of diseases.

Market Dynamics:

The global esoteric testing market is primarily driven by the rising incidence of chronic diseases, such as cancer, cardiovascular diseases, and autoimmune disorders. Esoteric tests enable healthcare professionals to identify specific genetic mutations and biomarkers associated with these diseases, facilitating early diagnosis and personalized treatment plans. Moreover, the growing adoption of precision medicine and targeted therapies further fuels the demand for esoteric testing.

However, the market faces certain challenges, including the high cost of esoteric tests and the lack of reimbursement policies. Esoteric tests are often expensive due to the specialized equipment and expertise required for their execution. Additionally, the limited coverage by insurance providers hinders the widespread adoption of these tests, particularly in developing regions.

Despite these challenges, the market presents several opportunities for growth. The increasing focus on preventive healthcare and the rising awareness about the benefits of early disease detection are expected to drive the demand for esoteric testing. Furthermore, advancements in technology, such as next-generation sequencing and molecular diagnostics, are likely to enhance the accuracy and efficiency of esoteric tests, opening new avenues for market expansion.

Key Features of the Study:

  • This report provides an in-depth analysis of the global esoteric testing market, including market size (US$ Billion) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), with 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • Key companies covered as a part of this study include LabCorp, Quest Diagnostics, OPKO Health, Miraca Holdings, Myriad Genetics, Sonic Healthcare, Cardio Diagnostics Holdings, Inc, Veravas, BPGbio, Inc., Fulgent Genetics, Alveo Technologies, Inc., and S.R.L. Diagnostics
  • Insights from this report would allow marketers and management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global esoteric testing market report caters to various stakeholders in this industry, including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global esoteric testing market

Esoteric Testing Market Segmentation

  • By Type
    • Endocrinology
    • Oncology
    • Molecular Diagnostics
    • Neurology
    • Immunology
    • Genetic Testing
    • Others
  • By Technology
    • Mass Spectrometry
    • Real Time PCR
    • Flow Cytometry
    • Chemiluminescence
    • ELISA
    • Radioimmunoassay
    • Others
  • By Service Provider
    • Independent & Reference Labs
    • Hospital-based Labs
    • Specialty Clinics
    • Others
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Top Companies in Esoteric Testing Market
    • LabCorp
    • Quest Diagnostics
    • OPKO Health
    • Miraca Holdings
    • Myriad Genetics
    • Sonic Healthcare
    • Cardio Diagnostics Holdings, Inc
    • Veravas
    • BPGbio, Inc.
    • Fulgent Genetics
    • Alveo Technologies, Inc.
    • S.R.L. Diagnostics

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Esoteric Testing, By Type
    • Market Esoteric Testing, By Technology
    • Market Esoteric Testing, By Service Provider
    • Market Esoteric Testing, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
  • Rising prevalence of chronic and infectious diseases
    • Restraints
  • High costs and inadequate reimbursements
    • Opportunities
  • Point-of-care esoteric testing
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Esoteric Testing Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Esoteric Testing Market, By Type, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Endocrinology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Oncology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Molecular Diagnostics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Neurology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Immunology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Genetic Testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

6. Esoteric Testing Market, By Technology, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019- 2030
    • Segment Trends
  • Mass Spectrometry
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Real Time PCR
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Flow Cytometry
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Chemiluminescence
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • ELISA
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Radioimmunoassay
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

7. Esoteric Testing Market, By Service Provider, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019- 2030
    • Segment Trends
  • Independent & Reference Labs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Hospital-based Labs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Specialty Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

8. Esoteric Testing Market, By Region, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Country, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Country 2019-2030
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Service Provider, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Service Provider, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Service Provider, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Service Provider, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Service Provider, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Service Provider, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • North Africa
  • Central Africa
  • South Africa

9. Competitive Landscape

  • LabCorp
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Quest Diagnostics
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • OPKO Health
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Miraca Holdings
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Myriad Genetics
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Sonic Healthcare
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Cardio Diagnostics Holdings, Inc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Veravas
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • BPGbio, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Fulgent Genetics
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Alveo Technologies, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • R.L. Diagnostics
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

10. Section

  • Research Methodology
  • About us